Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Equity Ratio (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Equity Ratio data on record, last reported at 0.55 in Q4 2025.

  • For Q4 2025, Equity Ratio changed N/A year-over-year to 0.55; the TTM value through Dec 2025 reached 0.55, changed N/A, while the annual FY2025 figure was 0.55, N/A changed from the prior year.
  • Equity Ratio reached 0.55 in Q4 2025 per RCUS's latest filing, up from 0.45 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.71 in Q1 2021 and bottomed at 0.42 in Q4 2023.
  • Average Equity Ratio over 5 years is 0.52, with a median of 0.51 recorded in 2022.
  • Peak YoY movement for Equity Ratio: decreased 27.36% in 2022, then increased 14.06% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.53 in 2021, then fell by 4.45% to 0.51 in 2022, then fell by 16.52% to 0.42 in 2023, then rose by 3.01% to 0.43 in 2024, then increased by 27.47% to 0.55 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.55 in Q4 2025, 0.45 in Q3 2025, and 0.46 in Q1 2025.